Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Benard VB, Watson M, Saraiya M, Harewood R, Townsend JS, Stroup AM, Weir HK, Allemani C.

Cancer. 2017 Dec 15;123 Suppl 24:5119-5137. doi: 10.1002/cncr.30906.

PMID:
29205300
2.

Cervical cancer screening in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in four US-Affiliated Pacific Islands between 2007 and 2015.

Senkomago V, Royalty J, Miller JW, Buenconsejo-Lum LE, Benard VB, Saraiya M.

Cancer Epidemiol. 2017 Oct;50(Pt B):260-267. doi: 10.1016/j.canep.2017.04.011.

3.

Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.

White MC, Shoemaker ML, Benard VB.

Am J Prev Med. 2017 Sep;53(3):392-395. doi: 10.1016/j.amepre.2017.02.024. Epub 2017 May 1.

PMID:
28473240
4.

Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era.

Benard VB, Castle PE, Jenison SA, Hunt WC, Kim JJ, Cuzick J, Lee JH, Du R, Robertson M, Norville S, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

JAMA Oncol. 2017 Jun 1;3(6):833-837. doi: 10.1001/jamaoncol.2016.3609.

5.

Change in Provider Beliefs Regarding Cervical Cancer Screening Intervals After an Educational Intervention.

Benard VB, Greek A, Roland KB, Hawkins NA, Lin L, Saraiya M.

J Womens Health (Larchmt). 2016 May;25(5):422-7. doi: 10.1089/jwh.2015.5706. Epub 2016 Apr 20.

PMID:
27096534
6.

Changes in Knowledge and Beliefs About Human Papillomavirus and Cervical Cancer Screening Intervals in Low-Income Women After an Educational Intervention.

Roland KB, Benard VB, Greek A, Hawkins NA, Lin L.

J Prim Care Community Health. 2016 Apr;7(2):88-95. doi: 10.1177/2150131915624869. Epub 2016 Jan 13.

7.

Racial and ethnic differences in human papillomavirus positivity and risk factors among low-income women in Federally Qualified Health Centers in the United States.

Lin L, Benard VB, Greek A, Hawkins NA, Roland KB, Saraiya M.

Prev Med. 2015 Dec;81:258-61. doi: 10.1016/j.ypmed.2015.08.027. Epub 2015 Sep 9.

8.

Communication practices about HPV testing among providers in Federally Qualified Health Centers.

Lin L, Benard VB, Greek A, Roland KB, Hawkins NA, Saraiya M.

Prev Med Rep. 2015;2:436-439.

9.
10.

Erratum to: The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women.

Benard VB, Royalty J, Saraiya M, Rockwell T, Helsel W.

Cancer Causes Control. 2015 May;26(5):721. doi: 10.1007/s10552-015-0586-4. No abstract available.

PMID:
25948086
11.

The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women.

Benard VB, Royalty J, Saraiya M, Rockwell T, Helsel W.

Cancer Causes Control. 2015 May;26(5):713-9. doi: 10.1007/s10552-015-0542-3. Epub 2015 Mar 10. Erratum in: Cancer Causes Control. 2015 May;26(5):721.

12.

Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007-2012.

Benard VB, Thomas CC, King J, Massetti GM, Doria-Rose VP, Saraiya M; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Nov 7;63(44):1004-9.

13.

Demographic factors associated with overuse of Pap testing.

Kepka D, Breen N, King JB, Meissner HI, Roland KB, Benard VB, Saraiya M.

Am J Prev Med. 2014 Nov;47(5):629-33. doi: 10.1016/j.amepre.2014.07.034. Epub 2014 Aug 27.

PMID:
25175763
14.

Primary care providers human papillomavirus vaccine recommendations for the medically underserved: a pilot study in U.S. Federally Qualified Health Centers.

Roland KB, Benard VB, Greek A, Hawkins NA, Saraiya M.

Vaccine. 2014 Sep 22;32(42):5432-5. doi: 10.1016/j.vaccine.2014.07.098. Epub 2014 Aug 12.

15.

National Breast and Cervical Cancer Early Detection Program data validation project.

Eheman CR, Leadbetter S, Benard VB, Blythe Ryerson A, Royalty JE, Blackman D, Pollack LA, Adams PW, Babcock F.

Cancer. 2014 Aug 15;120 Suppl 16:2597-603. doi: 10.1002/cncr.28825.

16.

Using data to effectively manage a national screening program.

Yancy B, Royalty JE, Marroulis S, Mattingly C, Benard VB, DeGroff A.

Cancer. 2014 Aug 15;120 Suppl 16:2575-83. doi: 10.1002/cncr.28821.

17.

Strengthening breast and cervical cancer control through partnerships: American Indian and Alaska Native Women and the National Breast and Cervical Cancer Early Detection Program.

Espey D, Castro G, Flagg T, Landis K, Henderson JA, Benard VB, Royalty JE.

Cancer. 2014 Aug 15;120 Suppl 16:2557-65. doi: 10.1002/cncr.28824.

18.

Impact of the National Breast and Cervical Cancer Early Detection Program on cervical cancer mortality among uninsured low-income women in the U.S., 1991-2007.

Ekwueme DU, Uzunangelov VJ, Hoerger TJ, Miller JW, Saraiya M, Benard VB, Hall IJ, Royalty J, Li C, Myers ER.

Am J Prev Med. 2014 Sep;47(3):300-8. doi: 10.1016/j.amepre.2014.05.016. Epub 2014 Jul 8.

PMID:
25015564
19.

Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies.

Saraiya M, Benard VB, Greek AA, Steinau M, Patel S, Massad LS, Sawaya GF, Unger ER.

Am J Obstet Gynecol. 2014 Oct;211(4):354.e1-6. doi: 10.1016/j.ajog.2014.05.001. Epub 2014 May 6.

20.

Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening.

Benard VB, Saraiya M, Greek A, Hawkins NA, Roland KB, Manninen D, Ekwueme DU, Miller JW, Unger ER.

J Womens Health (Larchmt). 2014 Mar;23(3):197-203. doi: 10.1089/jwh.2013.4655. Epub 2013 Dec 31.

21.

A population-based evaluation of cervical screening in the United States: 2008-2011.

Cuzick J, Myers O, Hunt WC, Robertson M, Joste NE, Castle PE, Benard VB, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):765-73. doi: 10.1158/1055-9965.EPI-13-0973. Epub 2013 Dec 3.

22.

Overuse of papanicolaou testing among older women and among women without a cervix.

Kepka D, Breen N, King JB, Benard VB, Saraiya M.

JAMA Intern Med. 2014 Feb 1;174(2):293-6. doi: 10.1001/jamainternmed.2013.12607. No abstract available.

23.

News from the CDC: collaborations to build capacity at the community level in cancer prevention and control.

Ekwenugo L, Benard VB, Vinson C.

Transl Behav Med. 2013 Mar;3(1):3-5. doi: 10.1007/s13142-012-0185-9.

24.

Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers.

Hawkins NA, Benard VB, Greek A, Roland KB, Manninen D, Saraiya M.

Prev Med. 2013 Nov;57(5):641-5. doi: 10.1016/j.ypmed.2013.08.021. Epub 2013 Sep 5.

25.

Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers.

Roland KB, Benard VB, Greek A, Hawkins NA, Manninen D, Saraiya M.

Prev Med. 2013 Nov;57(5):419-25. doi: 10.1016/j.ypmed.2013.04.012. Epub 2013 Apr 28.

26.

Cervical cancer screening among young adult women in the United States.

Roland KB, Benard VB, Soman A, Breen N, Kepka D, Saraiya M.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):580-8. doi: 10.1158/1055-9965.EPI-12-1266. Epub 2013 Jan 25.

27.

Cervical carcinoma rates among young females in the United States.

Benard VB, Watson M, Castle PE, Saraiya M.

Obstet Gynecol. 2012 Nov;120(5):1117-23. doi: http://10.1097/AOG.0b013e31826e4609.

28.

Cervical cancer screening measures need to evolve to continue to tell the story.

Saraiya M, Watson M, Benard VB.

J Womens Health (Larchmt). 2012 Nov;21(11):1128-9. doi: 10.1089/jwh.2012.3994. Epub 2012 Oct 16. No abstract available.

29.

Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program.

Benard VB, Howe W, Royalty J, Helsel W, Kammerer W, Richardson LC.

J Womens Health (Larchmt). 2012 Jul;21(7):776-82. doi: 10.1089/jwh.2011.3224. Epub 2012 Apr 16.

30.

Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States.

Roland KB, Soman A, Benard VB, Saraiya M.

Am J Obstet Gynecol. 2011 Nov;205(5):447.e1-8. doi: 10.1016/j.ajog.2011.06.001. Epub 2011 Jun 12.

PMID:
21840492
31.

Cancer screening practices among physicians in the national breast and cervical cancer early detection program.

Benard VB, Saraiya MS, Soman A, Roland KB, Yabroff KR, Miller J.

J Womens Health (Larchmt). 2011 Oct;20(10):1479-84. doi: 10.1089/jwh.2010.2530. Epub 2011 Jul 20.

32.

Breast cancer screening beliefs, recommendations and practices: primary care physicians in the United States.

Meissner HI, Klabunde CN, Han PK, Benard VB, Breen N.

Cancer. 2011 Jul 15;117(14):3101-11. doi: 10.1002/cncr.25873. Epub 2011 Jan 18.

33.

Impact of the 2002 American society for Colposcopy and Cervical Pathology guidelines on cervical cancer diagnosis in a geographically diverse population of commercially insured women, 1999-2004.

Martin CK, Richardson LC, Berkman ND, Kuo TM, Yuen AN, Benard VB.

J Low Genit Tract Dis. 2011 Jan;15(1):25-32. doi: 10.1097/LGT.0b013e3181ed3c2b.

PMID:
21192173
34.

US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening.

Wong C, Berkowitz Z, Saraiya M, Wideroff L, Benard VB.

Sex Health. 2010 Sep;7(3):338-45. doi: 10.1071/SH09115.

PMID:
20719225
35.

Content analysis of continuing medical education for cervical cancer screening.

Roland KB, Larkins TL, Benard VB, Berkowitz Z, Saraiya M.

J Womens Health (Larchmt). 2010 Apr;19(4):651-7. doi: 10.1089/jwh.2009.1928.

PMID:
20350199
36.

Timing of colposcopy after cervical cytologic abnormalities.

Kuo TM, Benard VB, Berkman ND, Martin CK, Richardson LC.

Obstet Gynecol. 2010 Mar;115(3):629-36. doi: 10.1097/AOG.0b013e3181cec0b5. Erratum in: Obstet Gynecol. 2010 Jun;115(6):1308.

PMID:
20177296
37.

Repeat pap testing and colposcopic biopsies in the underserved.

Trivers KF, Benard VB, Eheman CR, Royalty JE, Ekwueme DU, Lawson HW.

Obstet Gynecol. 2009 Nov;114(5):1049-56. doi: 10.1097/AOG.0b013e3181b8fc88.

PMID:
20168106
38.

Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005.

Richardson LC, Royalty J, Howe W, Helsel W, Kammerer W, Benard VB.

Am J Public Health. 2010 Sep;100(9):1769-76. doi: 10.2105/AJPH.2009.160184. Epub 2009 Dec 17.

39.

Follow-up for cervical abnormalities in a managed care plan, 1999-2004.

Benard VB, Berkman ND, Kuo T, Martin CK, Richardson LC.

Prev Med. 2010 Jan-Feb;50(1-2):81-5. doi: 10.1016/j.ypmed.2009.11.005. Epub 2009 Nov 22.

PMID:
19932710
40.

Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007.

Yabroff KR, Saraiya M, Meissner HI, Haggstrom DA, Wideroff L, Yuan G, Berkowitz Z, Davis WW, Benard VB, Coughlin SS.

Ann Intern Med. 2009 Nov 3;151(9):602-11. doi: 10.7326/0003-4819-151-9-200911030-00005.

PMID:
19884621
41.

Examining the association between socioeconomic status and potential human papillomavirus-associated cancers.

Benard VB, Johnson CJ, Thompson TD, Roland KB, Lai SM, Cokkinides V, Tangka F, Hawkins NA, Lawson H, Weir HK.

Cancer. 2008 Nov 15;113(10 Suppl):2910-8. doi: 10.1002/cncr.23742.

42.

Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005.

Benard VB, Howe W, Saraiya M, Helsel W, Lawson HW.

J Low Genit Tract Dis. 2008 Oct;12(4):300-6. doi: 10.1097/LGT.0b013e31817e308e.

PMID:
18820545
43.

Cervical cancer incidence in the United States by area of residence, 1998 2001.

Benard VB, Coughlin SS, Thompson T, Richardson LC.

Obstet Gynecol. 2007 Sep;110(3):681-6.

PMID:
17766618
44.

Can high-grade cervical lesions be managed in a single clinic visit?

Richardson LC, Benard VB.

Nat Clin Pract Oncol. 2006 Aug;3(8):420-1. No abstract available.

PMID:
16894384
45.

Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States).

Eheman CR, Benard VB, Blackman D, Lawson HW, Anderson C, Helsel W, Lee NC.

Cancer Causes Control. 2006 Feb;17(1):29-38.

PMID:
16411050
46.

Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women.

Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W.

Obstet Gynecol. 2005 Jun;105(6):1323-8.

PMID:
15932824
47.

Physician recommendation for papanicolaou testing among U.S. women, 2000.

Coughlin SS, Breslau ES, Thompson T, Benard VB.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1143-8.

48.

Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001.

Benard VB, Eheman CR, Lawson HW, Blackman DK, Anderson C, Helsel W, Thames SF, Lee NC.

Obstet Gynecol. 2004 Mar;103(3):564-71.

PMID:
14990422
49.

Activities of epidemiologists in state and territorial cancer control programs, 1999.

Benard VB, Bobo JK.

J Public Health Manag Pract. 2002 Mar;8(2):10-25.

PMID:
11889848

Supplemental Content

Loading ...
Support Center